| P2093 | author name string | Walmsley S | |
| | Lee EC | |
| | Fantus IG | |
| P2860 | cites work | Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature | Q28245752 |
| | Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function | Q28283866 |
| | Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 |
| | Banting lecture 1990. Beta-cells in type II diabetes mellitus | Q37633379 |
| | Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease | Q37742798 |
| | Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. | Q40452210 |
| | Drug-induced disorders of glucose tolerance | Q40880777 |
| | Diabetes mellitus following pentamidine-induced hypoglycemia in humans | Q41598739 |
| | HIV-protease inhibitors | Q41751665 |
| | A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors | Q43613003 |
| | Pathogenesis of NIDDM. A balanced overview | Q43832606 |
| | Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance | Q47886909 |
| | Immunological identification and localization of yeast aspartic protease 3-like prohormone-processing enzymes in mammalian brain and pituitary | Q48883036 |
| | Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. | Q51613168 |
| | Mechanism of FK506-induced glucose intolerance in rats | Q71642849 |
| | Didanosine-induced disorders of glucose tolerance | Q72544282 |
| | Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes | Q72787165 |
| | From the Food and Drug Administration | Q73558594 |
| | FDA warns of potential protease-inhibitor link to hyperglycaemia | Q73620151 |
| | Protease inhibitor-associated hyperglycaemia | Q73685253 |
| | Severe diabetes associated with protease inhibitor therapy | Q73907346 |
| | New-onset diabetes mellitus associated with use of protease inhibitor | Q73907352 |
| | Visceral abdominal-fat accumulation associated with use of indinavir | Q74390712 |
| | Megestrol for AIDS-related anorexia | Q93865745 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 161-164 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Canadian Medical Association Journal | Q5030320 |
| P1476 | title | New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review | |
| P478 | volume | 161 | |